Board Meeting21 May 2026, 05:42 pm
Eiko Lifesciences Board Meeting on May 26, 2026
AI Summary
Eiko Lifesciences Ltd has scheduled a Board of Directors meeting on May 26, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ending March 31, 2026. The trading window for designated persons remains closed from April 1, 2026, until 48 hours after the declaration of the results.
Key Highlights
- Eiko Lifesciences board to approve FY26 audited financial results.
- Meeting scheduled for May 26, 2026.
- Trading window closed until 48 hours post result declaration.
- Consideration of standalone and consolidated results.
Price Impact
More from EIKO